NCT00520338View on ClinicalTrials.gov

Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Postoperative PainThyroidectomyCyclooxygenase 2 Inhibitors
Interventions
DRUG

celecoxib

"1. placebo~2. celecoxib 400 mg oral single dose"

Trial Locations (1)

10700

Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT00520338 - Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter